Genetically Encoded Calcium Indicators for Neural Activity Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current calcium imaging techniques using synthetic indicators are invasive, difficult to target to specific cell types or sub-cellular locations, and have limitations in signal-to-noise ratio, response linearity, photostability, and protein stability, making them unsuitable for repeated, chronic in vivo measurements.

Innovation Solution

Development of genetically encoded calcium indicators (GECIs) with improved amino acid sequences, such as jGCaMP7 variants, which can be targeted to specific cell types and sub-cellular compartments, offering enhanced sensitivity, faster kinetics, and better signal resolution for neural activity measurements.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If synthetic calcium indicators are used for calcium imaging, then calcium measurement capability is achieved, but the procedure is invasive and damaging to neural tissue

Engineering Contradiction:
Improvecalcium measurement capabilityVSAvoiddamage to neural tissue
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent replaces synthetic chemical calcium indicators with genetically encoded calcium indicators (GECIs) that are expressed within neurons through genetic transformation. This substitution eliminates the need for invasive loading procedures while maintaining calcium measurement capability, as GECIs are naturally expressed and retained within the target cells.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

GECIs are self-contained molecular tools that are genetically encoded and expressed autonomously within the target neurons. The indicators are produced by the cells themselves through transcription and translation of the introduced genetic construct, eliminating the need for external loading and application of synthetic dyes.

Inventive Principle:
Principle #25Self-service

2Measurement precision

If synthetic calcium indicators are used, then calcium detection is possible, but targeting to specific cell types or sub-cellular locations is difficult

Engineering Contradiction:
Improvecalcium detection capabilityVSAvoidtargeting specificity
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent employs targeted expression strategies where GECI constructs are delivered to specific cell types through cell-type-specific promoters or viral vector targeting. Sub-cellular targeting is achieved by fusing the GECI to localization signals or anchoring domains that direct the protein to specific compartments such as dendrites, axons, or synapses, thereby achieving precise spatial localization.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent uses viral vectors as intermediaries to deliver GECI genetic constructs to specific neuronal populations. These vectors serve as mediators that enable selective transduction of target cell types based on receptor expression patterns, allowing precise cellular targeting without affecting other cell types.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Measurement precision

If synthetic calcium indicators are used, then calcium imaging can be performed, but repeated chronic in vivo measurements are precluded due to invasive loading

Engineering Contradiction:
Improvecalcium imaging capabilityVSAvoidduration of measurement capability
Core Design Contradiction:
Measurement precisionVSDuration of action of stationary object

Solution Approach 1:

The patent creates a permanent genetic copy of the GECI indicator within the neuronal genome or as a stable episomal element. This genetic integration allows the indicator to be continuously expressed and maintained in the cells over long periods, enabling repeated measurements without requiring re-loading of synthetic indicators.

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent achieves more than sufficient expression levels of GECI through optimized promoter strength and copy number control. The excessive expression ensures that even after prolonged in vivo recording periods, there is ample indicator protein remaining to maintain signal quality for repeated measurements.

Inventive Principle:
Principle #16Partial or excessive action

4Measurement precision

If previous GECI versions are used, then calcium indication is achieved, but sensitivity and kinetics are limited

Engineering Contradiction:
Improvecalcium indication capabilityVSAvoidsensitivity and kinetics
Core Design Contradiction:
Measurement precisionVSManufacturing precision

Solution Approach 1:

The patent employs systematic optimization of GECI protein sequences through site-directed mutagenesis to improve calcium binding affinity, fluorescence intensity, and response kinetics. Specific amino acid substitutions in the calcium-binding domains (such as in GCaMP variants) are made to enhance sensitivity and speed of response while maintaining genetic encodability.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The jGCaMP7 variants demonstrate improved sensitivity and kinetics for detecting action potentials, enabling more precise and repeated in vivo measurements of neural activity with better signal quality and stability compared to previous GECIs.

Implementation Method 1

determining a level of fluorescence produced by the cell

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Data Source

PatentUS11572401B2Genetically encoded calcium indicators and methods of use
Publication Date: 2023.02.07 HOWARD HUGHES MEDICAL INST

AI summary

Genetically encoded calcium indicator (GECI) polypeptides and the nucleic acid molecules encoding such polypeptides are provided. In addition, methods of using such nucleic acids and polypeptides in methods of screening for agonists or antagonists of G-protein coupled receptor (GPCR) or ion channels and methods of monitoring neural activity also are provided.